Elutia to divest bioenvelopes business to Boston Scientific for $88m [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
This transaction is stated to allow Elutia to advance its development and commercialisation efforts of its near-term pipeline without diluting shareholder value. The EluPro BioEnvelope comprises a “unique” extracellular matrix designed to facilitate the regeneration of healthy, vascularised tissue while preventing post-operative complications. The bioenvelope is designed to release rifampin and minocycline over an extended period at the surgical site, ensuring prolonged antibiotic delivery. The CanGaroo Envelope is made from acellular biologic material and aims to create a conducive environment for tissue healing by regulating the biological response to injury. Elutia CEO Dr Randy Mills said: “EluPro has clearly demonstrated that our proprietary drug-eluting biologics platform works at scale. “With the successful launch of EluPro, seven national group purchasing organisation contracts secured and more than 160 value analysis committee approvals, we have shown that we can de
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- A Strong Growth Profile Gives Boston Scientific Corp. (BSX) a Favorable Outlook [Yahoo! Finance]Yahoo! Finance
- Should New Institutional Support and Analyst Optimism Around Farapulse Reshape Boston Scientific (BSX) Investors' Thesis? [Yahoo! Finance]Yahoo! Finance
- What Analysts Think Is Changing In The Boston Scientific Growth Story [Yahoo! Finance]Yahoo! Finance
- Boston Scientific (BSX): Assessing Valuation After a Strong Multi-Year Run and Recent Pullback [Yahoo! Finance]Yahoo! Finance
- Boston Scientific: Gangbusters Growth, And A Valuation To Match [Seeking Alpha]Seeking Alpha
BSX
Earnings
- 10/22/25 - Beat
BSX
Sec Filings
- 12/8/25 - Form 3
- 12/2/25 - Form 4
- 12/1/25 - Form 4
- BSX's page on the SEC website